Not Tagged
Not Tagged
[]
fantastic and practice changing trial from the netherlands, sonia shows that cdk4/6i in 2nd line are as effective as in 1st line with less toxicity and cost.
this is what happens when you ask right questions and design studies to benefit patients instead of companies. #asco23 
Geriatric Oncologist @incmnszmx #gerionc, Global Oncology. @ASCO BOD 20-24, FASCO. PhD @UNAM_MX Opinions my own. 🇲🇽 https://t.co/GruVowjxCI…